Intellia Therapeutics NTLA
Last Price
52 Week Range
$5.90 - $28.25
Next Earnings Date
Feb 26 2026 (Estimate)
Next Earnings Date
Feb 26 2026 (Est.)
Last Price
NTLA Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Intellia Therapeutics, Inc. | 8-K | November 10, 2025 | |
Intellia Therapeutics, Inc. | 8-K | November 6, 2025 | |
Intellia Therapeutics, Inc. | 10-Q | November 6, 2025 | |
Intellia Therapeutics, Inc. | 8-K | October 29, 2025 | |
Intellia Therapeutics, Inc. | 8-K | October 27, 2025 | |
Intellia Therapeutics, Inc. | 8-K | September 25, 2025 | |
Intellia Therapeutics, Inc. | 10-Q | August 7, 2025 | |
Intellia Therapeutics, Inc. | 8-K | August 7, 2025 | |
Intellia Therapeutics, Inc. | 8-K | June 16, 2025 | |
Intellia Therapeutics, Inc. | 8-K | June 12, 2025 | |
Intellia Therapeutics, Inc. | 8-K | May 28, 2025 | |
Intellia Therapeutics, Inc. | 8-K | May 19, 2025 | |
Intellia Therapeutics, Inc. | 8-K | May 8, 2025 | |
Intellia Therapeutics, Inc. | 10-Q | May 8, 2025 | |
Intellia Therapeutics, Inc. | DEFA14A | April 30, 2025 | |
Intellia Therapeutics, Inc. | ARS | April 30, 2025 | |
Intellia Therapeutics, Inc. | DEF 14A | April 30, 2025 | |
Intellia Therapeutics, Inc. | 8-K | April 7, 2025 | |
Intellia Therapeutics, Inc. | 10-K | February 27, 2025 | |
Intellia Therapeutics, Inc. | 8-K | February 27, 2025 | |
Intellia Therapeutics, Inc. | 8-K | February 21, 2025 | |
Intellia Therapeutics, Inc. | 8-K | January 10, 2025 | |
Intellia Therapeutics, Inc. | 8-K | November 18, 2024 | |
Intellia Therapeutics, Inc. | 8-K | November 7, 2024 | |
Intellia Therapeutics, Inc. | 10-Q | November 7, 2024 | |
Intellia Therapeutics, Inc. | 8-K | October 25, 2024 | |
Intellia Therapeutics, Inc. | 8-K | August 8, 2024 | |
Intellia Therapeutics, Inc. | 10-Q | August 8, 2024 | |
Intellia Therapeutics, Inc. | 8-K | June 26, 2024 | |
Intellia Therapeutics, Inc. | 8-K | June 14, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.